176 related articles for article (PubMed ID: 10581384)
1. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.
Rezapkin GV; Douthitt M; Dragunsky E; Chumakov KM
Virus Res; 1999 Dec; 65(2):111-9. PubMed ID: 10581384
[TBL] [Abstract][Full Text] [Related]
2. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
3. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
[TBL] [Abstract][Full Text] [Related]
4. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
[TBL] [Abstract][Full Text] [Related]
5. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC
J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
7. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
[TBL] [Abstract][Full Text] [Related]
8. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
Georgopoulou A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
[TBL] [Abstract][Full Text] [Related]
9. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
10. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.
Guillot S; Otelea D; Delpeyroux F; Crainic R
Vaccine; 1994 May; 12(6):503-7. PubMed ID: 8036823
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
12. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW
Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054
[TBL] [Abstract][Full Text] [Related]
13. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.
Buttinelli G; Donati V; Fiore S; Marturano J; Plebani A; Balestri P; Soresina AR; Vivarelli R; Delpeyroux F; Martin J; Fiore L
J Gen Virol; 2003 May; 84(Pt 5):1215-1221. PubMed ID: 12692287
[TBL] [Abstract][Full Text] [Related]
16. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.
Svitkin YV; Cammack N; Minor PD; Almond JW
Virology; 1990 Mar; 175(1):103-9. PubMed ID: 2155504
[TBL] [Abstract][Full Text] [Related]
17. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R
Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049
[TBL] [Abstract][Full Text] [Related]
18. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
[TBL] [Abstract][Full Text] [Related]
19. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
20. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
